Adtalem Global Education (NYSE:CVSA) CFO Sells $1,262,100.00 in Stock

Posted by Geri Gentry on May 15th, 2026

Adtalem Global Education Inc. (NYSE:CVSA – Get Free Report) CFO Robert Phelan sold 10,000 shares of Adtalem Global Education stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $126.21, for a total transaction of $1,262,100.00. Following the transaction, the chief financial officer directly owned 55,806 shares in the company, valued at $7,043,275.26. This represents a 15.20% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

Adtalem Global Education stock opened at $126.55 on Friday. The company has a market capitalization of $4.31 billion, a PE ratio of 19.71, a P/E/G ratio of 1.07 and a beta of 0.63. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.70 and a current ratio of 0.70. Adtalem Global Education Inc. has a 1 year low of $86.97 and a 1 year high of $156.26. The firm’s 50 day moving average is $113.50.

Adtalem Global Education (NYSE:CVSA – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported $1.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.73 by $0.25. The firm had revenue of $487.03 million for the quarter. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The company’s quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.92 EPS. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, equities analysts expect that Adtalem Global Education Inc. will post 8.03 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on CVSA. Zacks Research cut shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Wall Street Zen cut shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Weiss Ratings began coverage on shares of Adtalem Global Education in a research report on Wednesday, February 25th. They set a “hold (c+)” rating on the stock. Barrington Research reiterated an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a research report on Friday, April 17th. Finally, Truist Financial lifted their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $155.00.

Get Our Latest Report on Adtalem Global Education

Adtalem Global Education Company Profile

(Get Free Report)

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.